AHA GUIDELINES Bundle (free trial)

Supraventricular Tachycardia

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/600060

Contents of this Issue

Navigation

Page 13 of 33

12 Treatment Table 9. Acute Treatment of AVNRT COR LOE Recommendations I B-R Vagal maneuvers are recommended for acute treatment in patients with AVNRT. I B-R Adenosine is recommended for acute treatment in patients with AVNRT. I B-NR Synchronized cardioversion should be performed for acute treatment in hemodynamically unstable patients with AVNRT when adenosine and vagal maneuvers do not terminate the tachycardia or are not feasible. I B-NR Synchronized cardioversion is recommended for acute treatment in hemodynamically stable patients with AVNRT when pharmacological therapy does not terminate the tachycardia or is contraindicated. IIa B-R IV beta blockers, diltiazem, or verapamil are reasonable for acute treatment in hemodynamically stable patients with AVNRT. IIb C-LD Oral beta blockers, diltiazem, or verapamil may be reasonable for acute treatment in hemodynamically stable patients with AVNRT. IIb C-LD IV amiodarone may be considered for acute treatment in hemodynamically stable patients with AVNRT when other therapies are ineffective or contraindicated.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Supraventricular Tachycardia